Can apixaban prevent venous thromboembolism better than rivaroxaban?

被引：0
|
作者：
Coleman, Craig I. [1 ,2 ]
Baker, William L. [1 ,2 ]
机构：
[1] Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA
[2] Univ Connecticut, Evidence Based Practice Ctr, Storrs, CT 06269 USA
来源：
LANCET HAEMATOLOGY | 2019年 / 6卷 / 04期
关键词：
D O I：
10.1016/S2352-3026(19)30022-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E179 / E179
页数：1
相关论文
共 50 条
  • [21] Budget impact analysis of apixaban to treat and prevent venous thromboembolism in Italy
    Bellone, Marco
    Di Virgilio, Roberto
    Di Rienzo, Paolo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2016, 17 (03) : 127 - 136
  • [22] Venous thromboembolism Risk of recurrence lower with rivaroxaban than aspirin
    Huynh, Karina
    NATURE REVIEWS CARDIOLOGY, 2017, 14 (05) : 3 - 3
  • [23] Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis
    Alotaibi, G.
    Alsaleh, K.
    Wu, C.
    McMurtry, M. S.
    INTERNATIONAL ANGIOLOGY, 2014, 33 (04) : 301 - 308
  • [24] Comparative effectiveness of apixaban versus rivaroxaban for the prevention of cardiovascular diseases and recurrent venous thromboembolism
    Dawwas, Ghadeer
    Park, Haesuk
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 35 - 35
  • [25] Comparative effectiveness and safety of edoxaban, rivaroxaban, and apixaban in patients with venous thromboembolism: A cohort study
    Fukasawa, Toshiki
    Seki, Tomotsugu
    Nakashima, Masayuki
    Kawakami, Koji
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (09) : 2083 - 2097
  • [26] COST-EFFECTIVENESS ANALYSIS OF APIXABAN AND RIVAROXABAN FOR TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM IN CHINA
    Gu, X.
    Wu, B.
    VALUE IN HEALTH, 2017, 20 (09) : A618 - A618
  • [27] Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweight
    Wysokinski, Waldemar E.
    Froehling, David A.
    Houghton, Damon E.
    McBane, Robert D.
    Vlazny, Danielle T.
    Bott-Kitslaar, Dalene M.
    Kuczmik, Wiktoria
    Sutkowska, Karolina
    Bator, Kaja
    Hodge, David O.
    Peterson, Lisa G.
    Casanegra, Ana, I
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (04) : 484 - 494
  • [28] Comparative safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism - a Danish nationwide study
    Sindet-Pedersen, C.
    Staerk, L.
    Pallisgaard, J. Langtved
    Gerds, T. Alexander
    Berger, J. S.
    Torp-Pedersen, C.
    Gislason, G.
    Olesen, J. Bjerring
    EUROPEAN HEART JOURNAL, 2017, 38 : 1035 - 1035
  • [29] Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes
    Ballerie, Alice
    Van, Remi Nguyen
    Lacut, Karine
    Galinat, Hubert
    Rousseau, Chloe
    Pontis, Adeline
    Nedelec-Gac, Fabienne
    Lescoat, Alain
    Belhomme, Nicolas
    Gueret, Pierre
    Mahe, Guillaume
    Couturaud, Francis
    Jego, Patrick
    Gouin-Thibault, Isabelle
    THROMBOSIS RESEARCH, 2021, 208 : 39 - 44
  • [30] Venous thromboembolism - Prevention is better than cure
    Shailendranath, L.
    Ting, S.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 270 : E29 - E29
12345